Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Synchron Inc.

Latest From Synchron Inc.

Start-Up Previews, May 2016

In this month's issue of Start-Up, we profile 4Tech, Advanced Cooling Therapy, Enumeral Biomedical Holdings, MiNDERA, PeptiMimesis and Synchron.

BioPharmaceutical Medical Device

Synchron Inc.

Synchron Inc. is developing what it believes is the first minimally invasive implantable brain device that could help paralyzed patients: its neural interface, Stentrode, consists of an electrode array built onto a self-expanding stent that is implanted in a cerebral blood vessel. Once the stent is implanted, the array is designed to record local neuronal activity, then translate that activity into a signal that could be used to manipulate mobility-assist devices and return movement to the paralyzed user.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Synchron Inc.
  • Senior Management
  • Thomas Oxley, MD, PhD, CEO
    Nicholas Opie, PhD, CTO
    Rahul Sharma, MD, Head, Bus. Dev.
  • Contact Info
  • Synchron Inc.
    Phone: (650) 687-9700
    1999 S. Bascom Ave.
    Ste. 700
    Campbell, CA 95008